首页> 美国卫生研究院文献>PLoS Clinical Trials >Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection
【2h】

Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection

机译:开发药物相互作用的证据评估和综合系统,并将其应用于对HIV和疟疾共感染的系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn all settings, there are challenges associated with safely treating patients with multimorbidity and polypharmacy. The need to characterise, understand and limit harms resulting from medication use is therefore increasingly important. Drug-drug interactions (DDIs) are prevalent in patients taking antiretrovirals (ARVs) and if unmanaged, may pose considerable risk to treatment outcome. One of the biggest challenges in preventing DDIs is the substantial gap between theory and clinical practice. There are no robust methods published for formally assessing quality of evidence relating to DDIs, despite the diverse sources of information. We defined a transparent, structured process for developing evidence quality summaries in order to guide therapeutic decision making. This was applied to a systematic review of DDI data with considerable public health significance: HIV and malaria.
机译:背景在所有情况下,安全治疗多种疾病和多种药物的患者都面临着挑战。因此,表征,理解和限制因使用药物引起的危害的需求变得越来越重要。药物相互作用(DDI)在服用抗逆转录病毒药物(ARV)的患者中很普遍,如果不加以控制,可能会对治疗结果构成相当大的风险。预防DDI的最大挑战之一是理论与临床实践之间的巨大差距。尽管信息来源多种多样,但尚未发布可靠的方法来正式评估与DDI相关的证据质量。我们定义了透明,结构化的流程来制定证据质量摘要,以指导治疗决策。这被用于对DDI数据进行系统的审查,该数据具有重大的公共卫生意义:艾滋病毒和疟疾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号